Abstract
It is well recognized that population heterogeneity plays an important role in the spread of epidemics. While individual variations in social activity are often assumed to be persistent, i.e. constant in time, here we discuss the consequences of dynamic heterogeneity. We integrate the stochastic dynamics of social activity into traditional epidemiological models. The overall epidemic dynamics is condensed to three differential equations and is characterized by an emergent long timescale. Our model captures multiple features of real-life epidemics such as COVID-19, including prolonged plateaus and multiple waves. Individual waves are suppressed at the state of Transient Collective Immunity (TCI), which subsequently degrades due to the dynamic nature of social activity. Our results also provide a new mechanism for emerging pathogens to transition from a fast-paced epidemic to the endemic state.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the University of Illinois System Office, the Office of the Vice-Chancellor for Research and Innovation, the Grainger College of Engineering, and the Department of Physics at the University of Illinois at Urbana-Champaign. This research was partially done at, and used resources of the Center for Functional Nanomaterials, which is a U.S. DOE Office of Science Facility, at Brookhaven National Laboratory under Contract No. DE-SC0012704
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Added COVID-19 to the title
Data Availability
The study uses only publicly available data
